GI Permeability Change in Response to Aquamin® | MicrobiomeTrials← Back to trialsNCT04855799
GI Permeability Change in Response to Aquamin®
CompletedPHASE2INTERVENTIONAL
Trial Details
Start: 2021-11-02Est. Completion: 2024-03-11
Enrollment target: 35 participants Locations- University of Michigan Hospital, Ann Arbor, Michigan, United States
Other microbiome trials you might be interested in
Inflammatory Bowel DiseaseCrohn's DiseaseUlcerative Colitis
Background:
Inflammatory bowel disease (IBD) is a term used to describe disorders that cause long-term inflammation in …
Bethesda, United StatesEst. completion Jun 1, 2036
Inflammatory Bowel Disease
Crohn's Disease (CD) and Ulcerative Colitis (UC), collectively known as inflammatory bowel disease (IBD), are two of the…
Chicago, United StatesEst. completion Sep 1, 2026
Recruiting
Ulcerative colitis (UC) is a chronic inflammatory bowel disease that requires regular monitoring of disease activity. Cu…
Asyut, EgyptEst. completion Jan 31, 2027